EP4329732A1 — Ionic liquid salts of active pharmaceutical ingredients
Assigned to Haleon US Holdings LLC · Expires 2024-03-06 · 2y expired
What this patent protects
A composition comprises a first active pharmaceutical ingredient, and an ionic liquid. The first active pharmaceutical ingredient can include ibuprofen or naproxen and the ionic liquid can comprise choline. The first active pharmaceutical ingredient and the ionic liquid together …
USPTO Abstract
A composition comprises a first active pharmaceutical ingredient, and an ionic liquid. The first active pharmaceutical ingredient can include ibuprofen or naproxen and the ionic liquid can comprise choline. The first active pharmaceutical ingredient and the ionic liquid together form an ionic salt. The composition can further comprise a second active pharmaceutical agent, such as acetaminophen.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.